Fellowship in Critical CarePharmacotherapy(FCCPT)

Overview

Fellowship in Critical Care Pharmacotherapy is a One Years Specialized Program in Critical Care for Doctor of Pharmacy (Pharm.D) graduates. The Program specializes as Clinical Pharmacotherapy Specialist in the delivery of Patient care services being an integral member of interprofessional critical care team and working to ensure the safe and effective use of medications in critically ill patients.

FCCPT Accredited Institutions ( Institutes and teachers )

Seq. No. Institute Location Duration Fulltime Teachers Associate Teachers Email Id Mobile No. Memb No. Annual Intake(Seats) Accredited Since Academic Coordinator
1 Iqraa Hospital, Calicut Calicut 1 & 2 years year courses Dr. SHIHABUDHEEN P   drshihabudheenp@gmail.com 8086430769 22/P-1337 2 16th July 2023

Dr Faris Hussain K

8848674731

gm@iqraahospital.in

2 Daya General Hospital, Thrissur, kerala Thrissur 1 & 2 year courses year courses Dr Fazil Abubakar   fazil_abu@yahoo.com 9176716919 11/A-332 2 8th August 2021

Archana K.

9497627217

daya.isccm@gmail.com

3 Apollo Hospitals Enterprise Limited, Navi Mumbai Navi Mumbai 1 & 2 years courses year courses Dr Akshaykumar Chhallani   akschhmrd@yahoo.com 9224687893 05/C-143 2 8th November 2018

Arpana Utekar

9136148882

arpana_u@apollohospitals.com

4 Bhagwan Mahavir Medica Supespeciality Hospital, Ranchi Ranchi 1 & 2 year courses year courses Dr Vijay Ku

Objectives

  • Apply knowledge of variable pathophysiology, pharmacology, and pharmaceutics in the critically ill patient to evaluate therapeutic options.
  • Discuss the impact of evidence-based decision-making and the role of clinical guidelines on pharmacotherapy management in critical care. (i.e., Clinical practice guidelines for the management of pain, sedation and delirium in the adult ICU; Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, etc.)
  • Design patient-specific therapeutic regimens, including monitoring parameters, for critically ill patients that are consistent with pharmacokinetic principles, practice guidelines, and evidence from contemporary literature, and effectively communicate this information to health care professionals
  • Adapt therapeutic regimens based on patient-specific clinical response, transitions of care and safety monitoring based on patient case scenarios, topic discussion, and assignments.
  • Write an evidence-based response to a drug information question that pertains to the care of a patient and/or addresses a therapeutic controversy.
  • Develop professional behaviors by working in teams, identifying roles and developing appropriate professional communications.

Duration and Eligibility

Duration of the Program:

12 months

Candidate Eligibility:

Doctor of Pharmacy (PharmD) degree from a PCI recognized university.

New Intake and Selection Process:

 

  • New applications will be done online from the ISCCM website.
  • New applications will be accepted from 1st of January.
  • The last date for registration will be 15th of February.
  • There will be provision for registering for the course with a late fee till 22nd of February.
  • Candidates need to apply directly to the institute. Selection will be done by respective institute based on candidate’s eligibility which should be confirmed by the individual teachers & institutes.

 

Institutional Eligibility:

All institutions accredited for IDCCM can offer this fellowship provided they have the required faculty mentioned below.

Faculty Requirement:

There should be a minimum of two teachers who qualify the following criteria - 1 Faculty.1 – An accredited IDCCM or IFCCM teacher , who will be designated as the institution’s course coordinator and be the contact person with the Indian College of Critical Care Medicine 1 Faculty 2- who has either PharmD or MD Pharmacology and Therapeutics (with minimum 3 years’ experience). His/Her credentials need to be vetted by the accreditations secretary and accredited by the Indian College of Critical Care Medicine before the institute is recognized to run this fellowship. (The minimum documents that will be needed to be submitted for accreditation are – certificate of completion of Pharm D or MD Pharmacology from an University recognized by PCI or NMC, respectively and a letter from the head of the institution that the person is working confirming that he/she has been working in the hospital as a clinical pharmacist for 3 years)

Number of candidates:

Each accredited institution is allowed to take a maximum of 2 candidates per academic year.

Guidelines

Guidelines for teachers for running the training program for the FCCP candidates.

This document intends to serve as a guideline for the hospitals/institution to optimize the training and education to FCCP candidates in delivering the pharmacotherapy services to critically ill patients. This document is prepared with reference to “The Society of Critical Care Medicine, USA and American College of Clinical Pharmacy Critical Care Practice and Research Network”.

 

  1. The FCCPT trainee should be trained to participate in regular rounds as a member of the interdisciplinary critical care team to provide comprehensive medication management (CMM) for all ICU patients.
  2. The FCCPT trainee should prospectively evaluate all drug therapy for appropriate indication, dose, drug interactions, drug allergies, and monitors the patient’s pharmacotherapeutic regimen for effectiveness and adverse drug events (ADEs), and intervenes as needed.
  3. As part of the interdisciplinary team, the FCCPT trainee should be trained on assisting healthcare professionals in discussions with patients and/or family members to help make informed decisions regarding pharmacotherapy options.
  4. The FCCPT trainee should be trained on performing medication reconciliation for ICU patients at the time of ICU admission, transfer from the ICU to the ward, or discharge to home or facility. Also. Performing the reviews of the medication history to determine which maintenance medications should be continued during the acute illness.
  5. The trainee should be trained on pharmacokinetic monitoring and therapeutic adjustments when a targeted drug is prescribed, in renal insufficiency, hepatic insufficiency, pediatric dose calculation, anticoagulant therapy monitoring, Pregnancy, Lactating women and Elderly patients with multiple comorbidities.
  6. The trainee should be trained on providing routine stewardship activities targeted at anti-infective (Escalation and de-escalation of antimicrobial as per the culture report) and other medications, including those that may be high risk for adverse events, high cost concerns, and inappropriate utilization (e.g., factor products, anticoagulants, sedatives, acid-suppressive therapies).
  7. In conjunction with the clinical dietitian, the FCCPT trainee should review the nutrition therapy plan and recommend modifications as indicated to optimize the nutritional regimen.
  8. The FCCPT trainee should document clinical activities that include, but are not limited to, disease state management, general pharmacotherapeutic monitoring, pharmacokinetic monitoring, ADEs, education and other patient care activities.
  9. The FCCPT trainee should be trained to serve as the medication safety leader for all aspects of the medication use system for critically ill patients in a designated clinical area through monitoring, assessment and recommendations for pharmacotherapy, interdisciplinary patient care and education to patient’s team members.
  10. The training should be on Facilitating the administration of medications to patients by assessing availability, route, compatibility, stability, and medication delivery technology to ensure timeliness, safety, and effectiveness.
  11. FCCPT trainee should be trained on monitoring a patient’s response to therapeutic regimens by using appropriate data in order to evaluate progress toward the goals of care, modify the plan of care as needed, and minimize adverse outcomes.
  12. The FCCPT trainee should be trained on participating as an integral team member in planning and implementation of processes for disaster, or mass causalities, scenarios as applicable to the critically ill patient.
  13. The FCCPT trainee should independently investigate or collaborate with other critical care healthcare team members to evaluate the impact of drug therapy protocols, guidelines, order sets, and/ or care pathways used in the ICU (e.g., drug administration, disease state management algorithms).
  14. The FCCPT trainees should be trained to coordinate the development and implementation of ICU-focused drug therapy protocols, guidelines, order sets, and/ or care pathways to maximize benefits of pharmacotherapy and also contributes to the hospital newsletter and drug monographs, on issues related to medication use in the ICU.
  15. The training should also focus on quality indicators of ICUs and collaborating with medical staff, nursing, other members of the healthcare team, and hospital administration to prepare the ICU for accreditation and to address any deficiencies identified.
  16. The training should emphasize on responding or coordinating to all resuscitation and time-dependent emergencies in the hospital including, but not limited to cardiac arrest, rapid response, trauma response, haemorrhagic shock, sepsis response, and acute neurologic life support.
  17. The training should include literature surveys, evidenced based practice and case report/studies publication.

 

Syllabus

A). Clinical Pharmacology, Pharmaceutical Care and Clinical Research

Patient-Centeredness in Pharmaceutical Care. Pharmacokinetics and pharmacodynamics consideration in Infants, Pediatrics, Pregnant, Lactating, Obese, Elderly Patients.

 

  • Evidence based medicine and Clinical Practice guidelines
  • Therapeutic Drug Monitoring
  • Adverse Drug Reactions
  • The principles and process of medication reconciliation - Comprehensive Medication Review/Assessment
  • Drug interactions (e.g., drug-drug, drug-nutrient, drug-disease) - Reassessment and modification of therapeutic regimens
  • Routes of administration for medications, fluids, and nutrition
  • Concepts of Pharmacogenomics
  • Drug Information Services
  • Clinical Research Methodology and Biostatistics (Clinical Study types, Regulatory requirements, Simple aspects of Study Design, Data Types- Probability and Sampling, Graphical Representation, Literature Surveys)

 

B). Critical Care Therapeutics

 

  1. Acute Illness Scoring Systems
    • Scoring Systems Acute Physiology and
    • Chronic Health Evaluation
    • Simplified Acute Physiology Score
    • Sequential Organ Failure Assessment Score
    • Multiple Organ Dysfunction Score
    • Therapeutic Intervention Scoring System
    • Injury Severity Score
  2. Basics of Tubes and Lines, Invasive Monitoring, and Hemodynamics
    • Intravascular Devices
    • Miscellaneous Lines and Tubes
    • Urinary Catheters
    • Rectal Tubes
    • Chest Tubes
    • Pressure Monitoring
    • Neurologic Monitoring Devices
    • Intra-abdominal Pressure (LAP)
    • Intra-aortic Balloon Pump (IABP)
    • Hemodynamic Monitoring
    • Devices for Measuring Hemodynamics
    • Normal Hemodynamic Values
  3. Basics of Mechanical Ventilation
    • History of Mechanical Ventilation
    • Indications for Mechanical Ventilation
    • Physics of Mechanical Ventilation
    • Positive Pressure Ventilation Terminology
    • Airway Pressures
    • Volumes
    • Oxygen
    • Ventilator Modes and Settings
    • Controlled Mechanical Ventilation
    • Assist/Control
    • Intermittent Mandatory Ventilation
    • Pressure vs. Volume Control
    • Airway Pressure Release Ventilation
    • High-Frequency Ventilation
    • Pressure Support
    • Positive End Expiratory Pressure
    • Continuous Positive Airway Pressure
    • Automatic Tube Compensation
    • Ventilator Parameters
    • Ventilator Settings Summary
    • Ventilator Complications
  4. Analgesia, Sedation, and Delirium Management
    • Pain and Sedation Scales
    • Pain Receptor Pharmacology, Pharmacotherapy of Pain
    • Sedation, Sedation Holiday/Daily Interruption
    • Delirium
    • Neuromuscular Blockers
    • Depolarizing Neuromuscular Blockers
    • Nondepolarizing Neuromuscular Blockers
  5. Acid–Base Fundamentals
    • Acid–Base Physiology
    • Assessment of Acid–Base Status
      • pH, Acid, Base, Base Deficit (Or Excess)
      • Acidosis or Alkalosis Alternative Assessment Approach of Acid–Base
    • Acid–Base Management
    • Acid–Base Abnormalities and Effects
  6. Fluid and Electrolyte Management
    • Water and Fluid Imbalances in the Critically Ill
    • Fluid Replacement
    • Trauma and Surgery
    • Traumatic Brain Injury
    • Sepsis
    • Sodium Homeostasis
    • Hyponatremia
    • Isotonic Hyponatremia
    • Hypertonic Hyponatremia
    • Hypotonic Hyponatremia
    • Hypernatremia
    • Potassium Homeostasis
    • Hypokalemia
    • Hyperkalemia
    • Magnesium Homeostasis
    • Hypomagnesemia
    • Hypermagnesemia
    • Phosphorus Homeostasis
    • Hypophosphatemia
    • Hyperphosphatemia
    • Calcium Homeostasis
    • Hypocalcemia
    • Hypercalcemia
  7. Cardiovascular Critical Care
    • Acute Coronary Syndrome Management (Treatment Protocols)
    • Acute Myocardial Infarction (ST-Elevation) Management
    • Perioperative Cardiovascular Management
    • Coronary Artery Bypass Graft Surgery and Valve Replacement
    • Acute Decompensated Heart Failure
    • Acute Arrhythmia Management
    • Advanced Cardiac Life Support
    • Medications in the Code Tray
    • Cardiopulmonary Resuscitation
  8. Acute Kidney Injury, Renal Replacement Therapies, and Medication Dose Adjustment
    • Acute Kidney Injury
    • Chronic Kidney Injury
    • Comparing Renal Replacement Therapies
    • Mechanisms and Contributing Factors in RRT
    • Dialysis, Complications, and Consideration
    • Drug Dosing During Dialysis
    • Drug Dosing in Renal Disease
  9. Nutrition Support in Critical Illness
    • Malnutrition in Critical Illness
    • Nutrition Assessment
    • Specialized Nutrition Support
    • Enteral Nutrition
    • Parenteral Nutrition
    • Energy Requirements
    • Parenteral Nutrition Formulations
    • Parenteral Nutrition Components: Macronutrients
    • Parenteral Nutrition Components: Micronutrients
      • A Step-Wise Approach to Writing a Parenteral Nutrition Order
    • Monitoring
  10. Antimicrobial Therapy in the Critically Ill
    • Factors Affecting Initial Antimicrobial Selection
    • Likely Pathogens Based on Site of Infection
    • Diagnostic Testing
    • Institution-Specific Considerations
    • Patient-Specific Considerations
      • Pharmacokinetic and Pharmacodynamics Considerations
    • Antimicrobial Resistance Considerations
    • Fungi Infection
    • Empiric Therapy Approaches
    • Sepsis and Septic Shock Management
    • Other Infections in the Intensive Care Unit
      • Potential Adverse Consequences of Antimicrobial Therapy
    • Induction of Resistance
    • Other Consequences of Antimicrobial Therapy
  11. Hematologic Diseases and Bleeding Complications of Critical Illness
    • Hemorrhagic Disorders
    • Anemias
    • Thrombotic Disorders
    • Oncologic Emergencies
  12. Pharmacotherapy of Neurotrauma and Neurologic Disease
    • Traumatic Brain Injury
    • Intracranial Hypertension
    • Seizure Prophylaxis and Seizure Management, Status Epilepticus
    • Cerebrovascular Disease
    • Spinal Cord Injury
    • Neuroprotection Hemodynamics and Neurogenic Shock
    • Neuromuscular Disease
    • Coma and Brain Death
  13. Gastrointestinal Disorders
    • Gastrointestinal Bleeding
    • Jaundice, Diarrhea, Obstruction, Pseudo obstruction
    • Acute Liver Failure
    • Acute Pancreatitis
    • Dosing adjustment in Liver Failure
  14. Pulmonary Disorders
    • Airways Management, Airways Obstruction
    • Acute Lungs Injury and Acute Respiratory Distress Syndrome
  15. Endocrine and Metabolic Diseases
    • Diabetic Ketoacidosis and Hypoglycemia
    • Thyroid Storm, Myxedema Coma, and Adrenal Crisis
  16. Environmental Emergencies and Miscellaneous
    • Temperature Related Illness
    • Burns
    • Poisoning and Drug Overdose
    • Snake Bite
    • Shock
    • Electrical Trauma
    • Critical Care of Pregnant Patient
    • Minimal Procedures in Critical Care and its Complication

 

Logbook

A log book to document the training that the candidates have undergone will be provided (Attached on line). All candidates are requested to have their log book filled up and attested by their teachers, in real time. The completed, attested log book needs to be submitted during the practical examination for assessment and evaluation. Candidates whodo not submit a completed log book will not be awarded a pass in their exanmination.

Click here to download log book format : Download

Mandatory Courses

It is mandatory for all candidates to have done the following two courses prior to appearing for their examination. They will have to produce the certificates of completion of these courses prior to registering for the examination.

BLS

Antibiotics Stewardship

An online STEP- FCCPT, similar to the STEP program for the IDCCM candidates will be conducted to make the training program uniform for the FCCP trainees. This would run over the period of 1 year and will happen once every 15 days, i.e. 2 classes in a month, with a total of 24 classes a year. 75% attendance for these classes will be mandatory for the candidates to make them eligible to appear for their examination.

These classes will be divided into two sections:

  • Section 1: Critical care Pharmacotherapeutics (Shall be covered by Critical Care Physician/Specialist).
  • Topics for section 1
    • Class 1: Acute illness scoring system in ICUs
    • Class 2: Basics of Mechanical Ventilator
    • Class 3: Pain and Delirium Management in ICU
    • Class 4: Acid-Base Abnormalities and Management
    • Class 5: Fluid and electrolyte management in ICU
    • Class 6: Acute Coronary Syndrome Management
    • Class 7: Shocks
    • Class 8: Nutrition support in ICU
    • Class 9: Antimicrobial therapy approaches in critically ill patients
    • Class 10: Bleeding complication in ICUs and Management
    • Class 11: Seizure Prophylaxis and Seizure Management, Status Epilepticus
    • Class 12: Environmental emergencies (Poisoning, Drug Overdose)
  • Section 2:Pharmacology and Pharmaceutical care (Shall be covered by Clinical Pharmacologist)
  • Topics for section 2
    • Class 1: Assessment of therapy and Medication Therapy Management
    • Class 2: Pharmacokinetic and Pharmacodynamics consideration in Critically illpatients
    • Class 2: Medication Reconciliation in ICU
    • Class 3: Therapeutic Drug Monitoring
    • Class 4: Pharmaceutical care Plan for ICU Patients
    • Class 5: Pharmacokinetics and pharmacodynamics consideration in Infants, Paediatrics, Elderly
    • Class 6: Pharmacokinetics and pharmacodynamics consideration Pregnant, Lactating, Obese Patients
    • Class 7: Drug interactions (e.g., drug-drug, drug-nutrient, drug-disease)
    • Class 8: Drug Dosing in Renal failure
    • Class 9: Drug Allergies and Anaphylaxis
    • Class 10: Rational Prescribing and Prescription writing
    • Class 11: Vaccines, Immune Globulins, other biologic products
    • Class 12: Medication Errors and Management

Course Structure:

  • Class room Training
  • Lectures
  • Case Discussion
  • Case Presentations
  • Journal Club PPT
  • Clinical Rotations/Postings
  • 12 Months of Clinical Rotations in Various Critical Care Units.

Suggested Clinical Rotation (1 Year)

Clinical Rotation Duration
Medical Intensive Care Unit (MICU) 3 months
Cardiac Care Unit (CCU) 1 months
Progressive Care Unit (PCU) 1 months
Neuro Intensive Care Unit (Neuro-ICU) 3 months
High Dependency Unit (HDU) 2 months
Emergency & Trauma Care 2 months

Exam Pattern

Written Exam-100 MCQs (Subject A- 30%, Subject B-70%)

Oral Exam:

  1. VIVA VOCE (50 Marks)
  2. OSCE (50 Marks)

*To pass each subjects candidate need to score 50% in Written and Oral Examination.

  • The written MCQ exam will be scheduled in March of every year, at designated Prometric centers in the country
  • Candidates who pass the written exam will be invited to the Oral/Practical examination that will be conducted in April of the same year and it will be in person (not web based). This will be conducted in institutions selected by the Indian College of Critical Care Medicine that will be designated as “Exam Centers”. Candidates that pass the practical examination will be awarded the Fellowship Certificate at the College Convocation.

Course Fee Details:

Rs 23,600* at the time of registration and mandatory ISCCM Associate Life Membership.